YD Bio Limited Ordinary Shares
YDES
Rank in Stocks
#12373
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company... Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Share Price
$6.71
Last synced: 2026-11-09
Market Cap
$475.28M
Change (1 day)
12.40%
Change (1 year)
-33.70%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade YD Bio Limited Ordinary Shares (YDES)
Category
Healthcare
Operating Margin for YD Bio Limited Ordinary Shares (YDES)
Operating Margin as of November 2026 TTM: -883.31%
According to YD Bio Limited Ordinary Shares's latest financial reports, its current operating margin (TTM) is -883.31%. At the end of 2025 the company had an operating margin of -883.31%.
Operating Margin history for YD Bio Limited Ordinary Shares from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -883.31% | 0.00% |
| 2025 | -883.31% | 208.36% |
| 2024 | -286.45% | 10,093.95% |
| 2023 | -2.81% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.04% |
US
|
|
| -149.01% | -99.83% |
US
|
|
| 25.57% | -100.03% |
AU
|
|
| 31.23% | -100.04% |
BE
|
|
| 29.35% | -100.03% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about YD Bio Limited Ordinary Shares's operating margin
What is YD Bio Limited Ordinary Shares's operating margin?
YD Bio Limited Ordinary Shares's operating margin is -883.31%, as of Nov 2026.
What was YD Bio Limited Ordinary Shares's operating margin in 2025?
In 2025, YD Bio Limited Ordinary Shares's operating margin was -883.31%, compared with -286.45% in 2024.
How has YD Bio Limited Ordinary Shares's operating margin changed since 2020?
From 2020 to 2025, YD Bio Limited Ordinary Shares's operating margin was highest in 2022 (0.00%) and lowest in 2025 (-883.31%).
How does YD Bio Limited Ordinary Shares's operating margin compare with similar companies?
YD Bio Limited Ordinary Shares's operating margin (-883.31%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.